[Federal Register Volume 75, Number 190 (Friday, October 1, 2010)]
[Pages 60767-60768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-24603]



Food and Drug Administration

[Docket No. FDA-2010-N-0506]

Office of the Commissioner; Request for Comments on the Food and 
Drug Administration Fiscal Year 2011-2015 Strategic Priorities 
Document; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION:  Notice; request for comments.


SUMMARY:  The Food and Drug Administration (FDA) is seeking public 
comment on its draft Strategic Priorities FY 2011-2015. FDA has 
identified these strategic priorities and goals that will guide its 
efforts to achieve its public health mission. FDA is seeking public 
comment to help further refine these priorities and goals.

DATES:  Submit either electronic or written comments by November 1, 

ADDRESSES: Submit electronic comments to http://www.regulations.gov. 
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT:  Darian Tarver, Office of Planning, 
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 
4219, Silver Spring, MD 20993-0002, 301-796-4850.


I. Background

    FDA is posting its draft Strategic Priorities FY 2011-2015 to 
ensure that key stakeholders are given an opportunity to comment on 
this document.
    The purpose of this document is to outline FDA's strategic 
intentions and plans for the next 5 years (fiscal year (FY) 2011 
through 2015). This document identifies four key cross-cutting 
strategic priorities and four strategic program goals that will guide 
efforts to achieve FDA's public health mission and to fulfill its role 
in supporting the larger mission and strategic goals of the Department 

[[Page 60768]]

Health and Human Services. The four cross-cutting strategic priorities 
are: (1) Advance Regulatory Science and Innovation, (2) Strengthen the 
Safety and Integrity of the Global Supply Chain, (3) Strengthen 
Compliance and Enforcement Activities to Support Public Health, and (4) 
Expand Efforts to Meet the Needs of Special Populations. The four 
strategic program goals are: (1) Advance Food Safety and Nutrition, (2) 
Promote Public Health by Advancing the Safety and Effectiveness of 
Medical Products, (3) Establish an Effective Tobacco Regulation, 
Prevention, and Control Program, and (4) Manage for Organizational 
Excellence and Accountability.
    The strategic planning process is an opportunity for FDA to further 
refine and strengthen the strategic management structure currently in 
place. For comparison purposes, the current FDA Strategic Action Plan 
2007 can be viewed at http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/StrategicActionPlan/UCM061415.pdf.
    FDA has made significant progress in its strategic planning 
efforts. As we build on this progress we look forward to receiving your 
comments by (see DATES). The text of the draft strategic priorities 
document is available in a ``pdf'' (portable document format) 
downloadable format through FDA's Web site: http://www.fda.gov/AboutFDA/.

II. Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments regarding this 
document. It is only necessary to send one set of comments. It is no 
longer necessary to send two copies of mailed comments. Identify 
comments with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: September 27, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-24603 Filed 9-30-10; 8:45 am]